Literature DB >> 10673770

Identification of a polymorphism in the promoter region of DRD4 associated with the human novelty seeking personality trait.

Y Okuyama1, H Ishiguro, M Nankai, H Shibuya, A Watanabe, T Arinami.   

Abstract

Polymorphism in the human dopamine D4 receptor gene (DRD4) exon III has been associated in some but not all studies of the human personality trait of Novelty Seeking. We searched for polymorphisms in the 5' region of DRD4 and identified six polymorphisms as follows: -1217G Ins/Del, -809G/A, -616C/G, -603T Ins/Del, -602(G)8-9, and -521C/T. Associations between these polymorphisms and personality traits measured by the Temperament and Character Inventory (TCI) were investigated in 86 healthy Japanese volunteers. The -521C/T polymorphism was significantly associated with Novelty Seeking (P = 0.0001). Subjects with the C/C genotype exhibited the highest Novelty Seeking scores and those with the T/T genotype exhibited the lowest. A transient expression method revealed that the T variant of the C-521T polymorphism reduces transcriptional efficiency. The present study suggests a contribution of dopamine D4 receptor availability to individual differences in Novelty Seeking behavior. Molecular Psychiatry (2000) 5, 64-69.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10673770     DOI: 10.1038/sj.mp.4000563

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  33 in total

Review 1.  Receptor pharmacogenetics: relevance to CNS syndromes.

Authors:  Sanober Shaikh; Robert W Kerwin
Journal:  Br J Clin Pharmacol       Date:  2002-10       Impact factor: 4.335

2.  Associations between DRDs and schizophrenia in a Korean population: multi-stage association analyses.

Authors:  Kyu Young Lee; Eun-Jeong Joo; Yong Ick Ji; Duk-Hwan Kim; Joo Bae Park; In-Won Chung; Sang Ick Lee; Yeon Ho Joo; Yong Min Ahn; Joo Yun Song; Yong Sik Kim
Journal:  Exp Mol Med       Date:  2011-01-31       Impact factor: 8.718

Review 3.  Novelty Seeking and Drug Addiction in Humans and Animals: From Behavior to Molecules.

Authors:  Taylor Wingo; Tanseli Nesil; Jung-Seok Choi; Ming D Li
Journal:  J Neuroimmune Pharmacol       Date:  2015-10-19       Impact factor: 4.147

4.  Association of dopamine D4 receptor (DRD4) exon III repeat polymorphism with temperament in 3-year-old infants.

Authors:  Alessandro De Luca; Mario Rizzardi; Anna Buccino; Rosina Alessandroni; Gian Paolo Salvioli; Nando Filograsso; Giuseppe Novelli; Bruno Dallapiccola
Journal:  Neurogenetics       Date:  2003-03-27       Impact factor: 2.660

5.  An association study of dopamine receptors polymorphisms and the Wisconsin Card Sorting Test in schizophrenia.

Authors:  J K Rybakowski; A Borkowska; P M Czerski; P Kapelski; M Dmitrzak-Weglarz; J Hauser
Journal:  J Neural Transm (Vienna)       Date:  2005-03-23       Impact factor: 3.575

6.  Attention-Deficit Hyperactivity Disorder in the post-genomic era.

Authors:  Philip Asherson
Journal:  Eur Child Adolesc Psychiatry       Date:  2004       Impact factor: 4.785

7.  The genetic architecture of selection at the human dopamine receptor D4 (DRD4) gene locus.

Authors:  E Wang; Y-C Ding; P Flodman; J R Kidd; K K Kidd; D L Grady; O A Ryder; M A Spence; J M Swanson; R K Moyzis
Journal:  Am J Hum Genet       Date:  2004-04-09       Impact factor: 11.025

8.  Mapping the genetic variation of executive attention onto brain activity.

Authors:  Jin Fan; John Fossella; Tobias Sommer; Yanghong Wu; Michael I Posner
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-28       Impact factor: 11.205

9.  Association of a polymorphism of the dopamine receptor D4 gene with bone mineral density in Japanese men.

Authors:  Yoshiji Yamada; Fujiko Ando; Naoakira Niino; Hiroshi Shimokata
Journal:  J Hum Genet       Date:  2003-11-07       Impact factor: 3.172

10.  Relationship between dopamine system genes and extraversion and novelty seeking.

Authors:  V E Golimbet; M V Alfimova; I K Gritsenko; R P Ebstein
Journal:  Neurosci Behav Physiol       Date:  2007-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.